Utility of a simplified [(18)F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applications
Name:
37780613.pdf
Size:
3.235Mb
Format:
PDF
Description:
Identified with Open Access button
Authors
Puri, TanujFrost, M. L.
Moore, A. E. B.
Choudhury, Ananya
Vinjamuri, S.
Mahajan, A.
Fynbo, C.
Vrist, M.
Theil, J.
Kairemo, K.
Wong, J.
Zaidi, H.
Revheim, M. E.
Werner, T. J.
Alavi, A.
Cook, G. J. R.
Blake, G. M.
Affiliation
Faculty of Biology, Medicine and Health, School of Medical Sciences, Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, United KingdomIssue Date
2023
Metadata
Show full item recordAbstract
We review the rationale, methodology, and clinical utility of quantitative [18F] sodium fluoride ([18F]NaF) positron emission tomography-computed tomography (PET-CT) imaging to measure bone metabolic flux (Ki, also known as bone plasma clearance), a measurement indicative of the local rate of bone formation at the chosen region of interest. We review the bone remodelling cycle and explain what aspects of bone remodelling are addressed by [18F]NaF PET-CT. We explain how the technique works, what measurements are involved, and what makes [18F]NaF PET-CT a useful tool for the study of bone remodelling. We discuss how these measurements can be simplified without loss of accuracy to make the technique more accessible. Finally, we briefly review some key clinical applications and discuss the potential for future developments. We hope that the simplified method described here will assist in promoting the wider use of the technique.Citation
Puri T, Frost ML, Moore AEB, Choudhury A, Vinjamuri S, Mahajan A, et al. Utility of a simplified [(18)F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applications. Front Endocrinol (Lausanne). 2023;14:1236881. PubMed PMID: 37780613. Pubmed Central PMCID: PMC10534005. Epub 2023/10/02. eng.Journal
Frontiers in EndocrinologyDOI
10.3389/fendo.2023.1236881PubMed ID
37780613Additional Links
https://dx.doi.org/10.3389/fendo.2023.1236881Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.3389/fendo.2023.1236881
Scopus Count
Collections
Related articles
- Input function and modeling for determining bone metabolic flux using [(18) F] sodium fluoride PET imaging: A step-by-step guide.
- Authors: Puri T, Frost ML, Moore AEB, Cook GJR, Blake GM
- Issue date: 2023 Apr
- The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer.
- Authors: Kulshrestha RK, Vinjamuri S, England A, Nightingale J, Hogg P
- Issue date: 2016 Dec
- More advantages in detecting bone and soft tissue metastases from prostate cancer using (18)F-PSMA PET/CT.
- Authors: Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE
- Issue date: 2019 Jan-Apr
- Therapy-induced bone changes in oncology imaging with (18)F-sodium fluoride (NaF) PET-CT.
- Authors: Ahmed N, Sadeq A, Marafi F, Gnanasegaran G, Usmani S
- Issue date: 2022 Apr
- A Prospective Study Comparing (99m)Tc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with (18)F-Fluoride PET/CT and (18)F-Fluoride PET/MRI for Diagnosing Bone Metastases.
- Authors: Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM
- Issue date: 2017 Nov